Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Costa

Showing results (1171-1180 of 1,198) with videos related to

Pageof 120
Sort By:
Pharmaceutics|February 24, 2024
Antiviral Action against SARS-CoV-2 of a Synthetic Peptide Based on a Novel Defensin Present in the Transcriptome of the Fire Salamander (<i>Salamandra salamandra</i>)Ana Luisa A N Barros, Vladimir C Silva, Atvaldo F Ribeiro-Junior, et al.
Neuron|November 4, 2015
ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule FunctionTetsuro Murakami, Seema Qamar, Julie Qiaojin Lin, et al.
The Lancet. Oncology|May 3, 2005
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLuisa L Villa, Ronaldo L R Costa, Carlos A Petta, et al.
Parasite (Paris, France)|April 14, 2021
In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasisCamila S Freitas, Daniela P Lage, João A Oliveira-da-Silva, et al.
Journal of Medical Virology|December 6, 2024
Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever PatientsAndré N A Gonçalves, Priscilla R Costa, Mateus V Thomazella, et al.
Frontiers in Immunology|October 31, 2017
Global Assessment of Dengue Virus-Specific CD4<sup>+</sup> T Cell Responses in Dengue-Endemic AreasAlba Grifoni, Michael A Angelo, Benjamin Lopez, et al.
European Child & Adolescent Psychiatry|October 23, 2025
Do white matter microstructural alterations associated with childhood maltreatment explain psychopathology in early adulthood?-a longitudinal neuroimaging studyRita Pasion, Sofia Amaoui, Tiago O Paiva, et al.
Parasitology Research|November 16, 2020
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasisCamila S Freitas, João A Oliveira-da-Silva, Daniela P Lage, et al.
Frontiers in Medicine|October 16, 2023
Corrigendum: Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): a study protocol for a randomized clinical trialMauro F F Mediano, Leonardo G Ribeiro, Rudson S Silva, et al.
Frontiers in Medicine|January 23, 2023
Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): A study protocol for a randomized clinical trialMauro F F Mediano, Leonardo G Ribeiro, Rudson S Silva, et al.
Pageof 120

Showing results (1171-1180 of 1,198) with videos related to

Sort By:
Pageof 120
Pharmaceutics|February 24, 2024
Antiviral Action against SARS-CoV-2 of a Synthetic Peptide Based on a Novel Defensin Present in the Transcriptome of the Fire Salamander (<i>Salamandra salamandra</i>)Ana Luisa A N Barros, Vladimir C Silva, Atvaldo F Ribeiro-Junior, et al.
Neuron|November 4, 2015
ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule FunctionTetsuro Murakami, Seema Qamar, Julie Qiaojin Lin, et al.
The Lancet. Oncology|May 3, 2005
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLuisa L Villa, Ronaldo L R Costa, Carlos A Petta, et al.
Parasite (Paris, France)|April 14, 2021
In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasisCamila S Freitas, Daniela P Lage, João A Oliveira-da-Silva, et al.
Journal of Medical Virology|December 6, 2024
Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever PatientsAndré N A Gonçalves, Priscilla R Costa, Mateus V Thomazella, et al.
Frontiers in Immunology|October 31, 2017
Global Assessment of Dengue Virus-Specific CD4<sup>+</sup> T Cell Responses in Dengue-Endemic AreasAlba Grifoni, Michael A Angelo, Benjamin Lopez, et al.
European Child & Adolescent Psychiatry|October 23, 2025
Do white matter microstructural alterations associated with childhood maltreatment explain psychopathology in early adulthood?-a longitudinal neuroimaging studyRita Pasion, Sofia Amaoui, Tiago O Paiva, et al.
Parasitology Research|November 16, 2020
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasisCamila S Freitas, João A Oliveira-da-Silva, Daniela P Lage, et al.
Frontiers in Medicine|October 16, 2023
Corrigendum: Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): a study protocol for a randomized clinical trialMauro F F Mediano, Leonardo G Ribeiro, Rudson S Silva, et al.
Frontiers in Medicine|January 23, 2023
Home-based exercise program in the indeterminate form of Chagas disease (PEDI-CHAGAS study): A study protocol for a randomized clinical trialMauro F F Mediano, Leonardo G Ribeiro, Rudson S Silva, et al.
Pageof 120